Current research shows that androgen regulation in PCOS has been the most extensively studied, with various treatment mechanisms identified, including the upregulation of LDHA, HK2, and PKM2 expression, as well as the modulation of pathways such as IRE1α-XBP1 and ERK. The gene discussed is XBP1; the disease is polycystic ovary syndrome.